Search

everythinglearnresearchcommunity

for

Search:↓

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Two mouse mutations cause similar hair loss despite different skin changes.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Finasteride improves immune response and reduces organ damage after trauma hemorrhage in mice.

Fat cells are important for tissue repair and stem cell support in various body parts.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

Atopic dermatitis increases the risk of some autoimmune diseases.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Immune cells affect hair growth and could lead to new hair loss treatments.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.